Search
Browse Categories

OvaDx® Ovarian Cancer Test


Price: $700.00
Item Number: OVADX
Arrayit Corporation provides the market’s first large panel test for ovarian cancer samples. OvaDx® is an advanced microarray-based test that measures the activation of the immune system in blood samples in response to early and late stage ovarian tumor cell formation. Pre-clinical studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Arrayit offers OvaDx® for research purposes pending 510(k) FDA approval. OvaDx® can be used to analyze samples derived from different tumor types and stages, the effectiveness of experimental chemotherapies, biomarker profiles in breast cancer and other epithelial cancers samples, studies of benign gynecological tumors, the effectiveness of ovarian cancer lead compounds, and for comparative research studies of existing tests including CA-125, OVA1®, and transvaginal ultrasound. OvaDx® will be available for sale upon FDA approval through our subsidiary Avant Diagnostics, Inc.
 

Additional Information

Click here for complete product information

Mailing Lists
Shopping Cart
Your cart is empty.